Seibt Matthew 4
4 · Acer Therapeutics Inc. · Filed Sep 23, 2019
Insider Transaction Report
Form 4
Seibt Matthew
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-09-18+50,000→ 50,000 totalExercise: $3.42Exp: 2019-09-18→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as follows: 50% on 01/01/2021 and 50% on 01/01/2022.